TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Boston Scientific Nordic AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,415,170
|
1,341,824
|
1,195,444 |
| Financial expenses |
153
|
818
|
452 |
| Earnings before taxes |
36,918
|
42,923
|
31,901 |
| EBITDA |
43,146
|
49,321
|
39,075 |
| Total assets |
503,517
|
443,594
|
420,909 |
| Current assets |
480,914
|
422,425
|
402,136 |
| Current liabilities |
257,086
|
228,305
|
233,909 |
| Equity capital |
246,431
|
215,289
|
187,000 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
136
|
126
|
120 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.9%
|
48.5%
|
44.4% |
| Turnover per employee |
10,406
|
10,649
|
9,962 |
| Profit as a percentage of turnover |
2.6%
|
3.2%
|
2.7% |
| Return on assets (ROA) |
7.4%
|
9.9%
|
7.7% |
| Current ratio |
187.1%
|
185.0%
|
171.9% |
| Return on equity (ROE) |
15.0%
|
19.9%
|
17.1% |
| Change turnover |
73,346
|
146,380
|
106,192 |
| Change turnover % |
5%
|
12%
|
10% |
| Chg. No. of employees |
10
|
6
|
7 |
| Chg. No. of employees % |
8%
|
5%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.